Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Cancer treatments Stories

2013-01-09 09:53:52

Patients with non-small-cell lung cancer survive longer if they are taking beta-blockers while receiving radiotherapy, according to a study of 722 patients published in the cancer journal Annals of Oncology today (Wednesday). Researchers at the University of Texas MD Anderson Cancer Center (Houston, USA) reviewed the progress and outcomes of patients who had received radiotherapy as their main or first line of treatment for cancer (known as "definitive radiotherapy" i.e. radiotherapy that...

2013-01-07 10:06:25

Surgery ranks as the most cost-effective type of treatment, according to UCSF-led study The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team of researchers at the University of California, San Francisco (UCSF). Appearing in the British Journal of Urology International, the work analyzed 232 papers published in the last...

2013-01-03 08:24:57

SAN DIEGO, Jan. 3, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will provide a corporate update and outline of anticipated 2013 milestones at Biotech Showcase 2013 on Tuesday, January 8 at 3:45 pm PT. The presentation will be held in Room Mission II (Track C) at the Parc 55 Wyndham San Francisco-Union...

Drug Substitions Due To Shortages Could Prove Harmful For Cancer Patients
2012-12-27 13:20:56

Lee Rannals for redOrbit.com — Your Universe Online According to research led by St. Jude Children's Research Hospital, there is a connection between higher rates of relapse in pediatric cancer patients and drug shortages. A national drug shortage was linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin's lymphoma, according to the national study. Survival from the condition went from 88 to 75 percent in two years after the drug...

2012-12-26 16:21:07

National study connects higher rates of relapse in pediatric cancer patients to drug shortage, offering first example of patients hurt by shortages and renewing calls to protect patient access to lifesaving treatments MEMPHIS, Tenn., Dec. 26, 2012 /PRNewswire-USNewswire/ -- A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude...

Mistletoe Extract Shows Promise As Colon Cancer Treatment
2012-12-23 06:22:09

redOrbit Staff & Wire Reports - Your Universe Online While it has become an iconic symbol of holiday romance, mistletoe may contain a substance that could help in the treatment of colon cancer, researchers from the University of Adelaide in Australia discovered in a recent study. The research, which was featured in a Huffington Post article published Friday, discovered the plant's extract was actually more effective in eliminating colon cancer cells than chemotherapy. Furthermore,...

2012-12-13 08:26:07

AMES, Iowa, Dec. 13, 2012 /PRNewswire/ -- NewLink Genetics Corporation (Nasdaq: NLNK) today announced that the results of a Phase 1 dose escalation study with its proprietary HyperAcute Prostate Cancer Immunotherapy were published in the Journal of Immunotherapy. The article, entitled "Cellular Immunotherapy Study of Prostate Cancer Patients and Resulting IgG Responses to Peptide Epitopes Predicted From Prostate Tumor-associated Autoantigens," is featured in the current edition of the...

2012-12-11 16:24:17

WINSTON-SALEM, N.C., Dec. 11, 2012 /PRNewswire-USNewswire/ -- When Teresa Thorn started getting nausea last February, she thought it was an ulcer, something she'd had years earlier. As the days went on, though, the nausea remained and Thorn's color started changing, something her co-workers noticed. Finally one Sunday, she and her mother, Naomi Ivester, went to the Emergency Department at Wake Forest Baptist Medical Center, where a battery of tests began. Her longtime physician at Wake...

2012-12-11 16:10:39

A review in the December issue of the journal Archives of Pathology & Laboratory Medicine by Paul Bunn Jr, MD, University of Colorado Cancer Center investigator and past president of ASCO, IASLC and AACI describes the current state of lung cancer care. “We´re in a new paradigm in which we realize this top cause of cancer deaths is actually a number of related diseases, each potentially with its own cause and cure,” Bunn says. The review describes the shift from...

2012-12-11 12:00:01

Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical trial led by investigators at Dana-Farber/Children's Hospital Cancer Center in Boston. The trial leaders will present the results of the Dana-Farber Cancer Institute ALL Consortium study, which involved nearly 500 patients under age 18 with B-precursor acute...